Efficacy and safety of ceritinib in patients with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): An update of ASCEND-1 Meeting Abstract


Authors: Kim, D.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, M.; Liu, G.; Santoro, A.; Geraldes, M.; Boral, A. L.; Yovine, A.; Shaw, A. T.
Abstract Title: Efficacy and safety of ceritinib in patients with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): An update of ASCEND-1
Meeting Title: 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 90
Issue: 5 Suppl.
Meeting Dates: 2014 Oct 30-Nov 1
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2014-11-15
Start Page: S33
End Page: S34
Language: English
ACCESSION: WOS:000346413500071
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2014.08.208
Notes: Meeting Abstract: 169 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely